DaVita Inc. (NYSE:DVA) Stake Boosted by Moran Wealth Management LLC

Moran Wealth Management LLC boosted its stake in DaVita Inc. (NYSE:DVA - Free Report) by 6.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,204 shares of the company's stock after buying an additional 6,882 shares during the period. Moran Wealth Management LLC owned 0.15% of DaVita worth $17,929,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its holdings in shares of DaVita by 9.1% in the 4th quarter. Wellington Management Group LLP now owns 2,711 shares of the company's stock worth $405,000 after acquiring an additional 227 shares during the period. Fifth Third Bancorp increased its stake in shares of DaVita by 5.0% in the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock valued at $654,000 after purchasing an additional 204 shares during the period. Proficio Capital Partners LLC bought a new stake in shares of DaVita during the fourth quarter valued at approximately $5,636,000. SG Americas Securities LLC acquired a new position in shares of DaVita during the first quarter worth approximately $846,000. Finally, SBI Securities Co. Ltd. bought a new position in DaVita in the 4th quarter worth approximately $41,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Price Performance

NYSE DVA traded up $4.56 on Tuesday, reaching $140.90. The company's stock had a trading volume of 726,202 shares, compared to its average volume of 871,603. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. The firm's 50 day moving average is $139.55 and its two-hundred day moving average is $149.86. The stock has a market cap of $10.64 billion, a PE ratio of 13.96, a PEG ratio of 0.94 and a beta of 1.11.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the firm posted $2.26 earnings per share. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on DVA. Truist Financial decreased their price target on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research note on Monday, May 19th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, DaVita currently has a consensus rating of "Hold" and a consensus target price of $164.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.